The Trump administration has signaled it's behind the psychedelic renaissance, but there are still big questions about how these drugs will be administered once they are approved by the FDA.
The Trump administration has signaled it's behind the psychedelic renaissance, but there are still big questions about how these drugs will be administered once they are approved by the FDA. NPR does not offer or accept money for coverage or interviews. Anyone who makes such an offer or request is not an NPR employee and does not represent NPR.
Extract — continue reading at the source.
Related stories
RFK Jr. headlines sold-out anti-vaccine conference alongside Andrew Wakefield
Trump administration changes how it counts measles deaths amid Pennsylvania outbreak
Step, stand, stairs
What's the latest with the Trump admin's promise on lower drug prices in Medicaid?
Staff slept while patient killed at NHS mental health unit
Legionnaires’ disease bacteria found at Yankee Stadium amid deadly Bronx outbreak